250 related articles for article (PubMed ID: 31773415)
21. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers.
Rai V; Abdo J; Agrawal DK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834728
[TBL] [Abstract][Full Text] [Related]
23. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
[TBL] [Abstract][Full Text] [Related]
25. Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma.
Dunbar KJ; Karakasheva TA; Tang Q; Efe G; Lin EW; Harris M; Sahu V; Sachdeva UM; Hu J; Klein-Szanto AJ; Henick B; Diehl JA; Nakagawa H; Rustgi AK
Mol Cancer Res; 2023 Jul; 21(7):741-752. PubMed ID: 37027010
[TBL] [Abstract][Full Text] [Related]
26. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.
El Gammal AT; Melling N; Reeh M; Gebauer F; Mann O; Perez D; Bockhorn M; Bachmann K; Izbicki JR; Grupp K
Exp Mol Pathol; 2019 Apr; 107():51-56. PubMed ID: 30707896
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
29. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Lu CL; Ji Y; Ge D; Guo J; Ding JY
Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
Du J
Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma.
Yang B; Zhou ZH; Chen L; Cui X; Hou JY; Fan KJ; Han SH; Li P; Yi SQ; Liu Y
Cancer Med; 2018 May; 7(5):1756-1765. PubMed ID: 29577671
[TBL] [Abstract][Full Text] [Related]
32. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
34. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
[TBL] [Abstract][Full Text] [Related]
35. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
36. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
37. FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.
Islam F; Gopalan V; Law S; Tang JC; Lam AK
Hum Pathol; 2019 May; 87():1-10. PubMed ID: 30794892
[TBL] [Abstract][Full Text] [Related]
38. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
[TBL] [Abstract][Full Text] [Related]
39. Stromal interaction molecule 1 promotes tumor growth in Esophageal squamous cell carcinoma.
Tang J; Ye S; Wang M; Li J; Meng X; Liu F
Genomics; 2020 May; 112(3):2146-2153. PubMed ID: 31843504
[TBL] [Abstract][Full Text] [Related]
40. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
